Genetic alterations in 'normal' luminal and myoepithelial cells of the breast

Journal of Pathology

Volumn 189, Issue 4, 1999, Pages 496-503

  Lakhani, Sunil R ^a   Chaggar, Ranbir ^b   Davies, Susan ^a   Jones, Chris ^a   Collins, Nadine ^c   Odel, Christopher ^b   Stratton, Michael R ^c   O'Hare, Michael J ^a  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^b LUDWIG INSTITUTE FOR CANCER RESEARCH   (United Kingdom)

^c INSTITUTE OF CANCER RESEARCH   (United Kingdom)

Author keywords

Breast; Epithelium; Genetic alteration; Loss of heterozygosity; Luminal; Myoepithelium; Normal tissue

Indexed keywords

ARTICLE; BREAST CANCER; BREAST CARCINOGENESIS; BREAST REDUCTION; CHROMOSOME 11P; CHROMOSOME 13Q; CHROMOSOME 17Q; CLINICAL ARTICLE; DISEASE ASSOCIATION; HETEROZYGOSITY LOSS; HUMAN; HUMAN TISSUE; MYOEPITHELIUM CELL; PRIORITY JOURNAL;

ADULT; AGED; BREAST; BREAST NEOPLASMS; BREAST NEOPLASMS, MALE; CARCINOMA, DUCTAL, BREAST; CLONE CELLS; FEMALE; GENES, BRCA1; GENETIC MARKERS; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; LOSS OF HETEROZYGOSITY; MALE; MIDDLE AGED;

EID: 0032694152     PISSN: 00223417     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9896(199912)189:4<496::AID-PATH485>3.0.CO;2-D     Document Type: Article

References (25)

1. Cardiff RD, Muller WJ. Transgenic mouse models of mammary tumorigenesis. Cancer Surv 1993; 16: 97-113.
2. Morris DW, Cardiff RD. The multistep model of mouse mammary tumour development. Adv Virol Oncol 1987; 7: 123-140.
3. Dupont WD, Page DL. Risk factors for breast cancer in women with proliferative breast disease. N Engl J Med 1985; 312: 146-151.
4. Stratton MR, Collins N, Lakhani SR, Sloane JP. Loss of heterozygosity in ductal carcinoma in situ of the breast. J Pathol 1995; 175: 195-201.
5. Lakhani S, Collins N, Sloane J, Stratton M. Loss of heterozygosity in lobular carcinoma in situ of the breast. J Clin Pathol: Mol Pathol 1995; 48: M74-M78.
6. Lakhani SR, Collins N, Stratton MR, Sloane JP. Atypical ductal hyperplasia of the breast: clonal proliferation with loss of heterozygosity on chromosomes 16q and 17p. J Clin Pathol 1995; 48: 611-615.
7. Lakhani S, Slack D, Hamoudi R, Collins N, Stratton M, Sloane J. Detection of alleleic imbalance indicates that a proportion of mammary hyperplasia of usual type are clonal, neoplastic proliferations. Lab Invest 1996; 74: 129-135.
8. Deng G, Lu Y, Zlotnikov G, Thor AD, Smith HS. Loss of heterozygosity in normal tissue adjacent to breast carcinomas. Science 1996; 274: 2057-2059.
9. National Coordinating Group for Breast Screening Pathology. Pathology Reporting in Breast Cancer Screening (2nd edn). NHSBSP Publications No. 3. Sheffield, UK 1995.
10. Welt S, Divgi CR, Scott AM, et al. Antibody targeting in metastatic colon cancer: a phase I study of monoclonal antibody F19 against a cell-surface protein of reactive tumor stromal fibroblasts. J Clin Oncol 1994; 12: 1193-1203.
11. O'Hare M, Ormerod MG, Monaghan P, Lane EB, Gusterson BA. Characterization in vitro of luminal and myoepithelial cells isolated from the human mammary gland by cell sorting. Differentiation 1991; 46: 209-221.
12. O'Hare M. Breast cancer. In Human Cancer in Primary Culture. A Handbook, Masters J (ed.). Kluwer: Dordrecht, 1990; 271-286.
13. Weber J, Kwitek AE, May PE, Wallace MR, Collins FS, Ledbetter DH. Dinucleotide repeat polymorphisms at the D17S250 and D17S261 loci. Nuceicl Acid Res 1990; 18: 4640.
14. Weissenbach J, Gyapay G, Dib C, et al. A second generation linkage map of the human genome. Nature 1992; 359: 794-797.
15. Merajver SD, Frank TS, Xu J, et al. Germline BRCA1 mutations and loss of the wild-type allele in tumors from families with early onset breast and ovarian cancer. Clin Cancer Res 1995; 1: 539-544.
16. Tirkkonen M, Tanner M, Karhu R, Kallioniemi A, Isola J, Kallioniemi OP. Molecular cytogenetics of primary breast cancer by CGH. Genes Chromosomes Cancer 1998; 21: 177-184.
17. Larson PS, de las Morenas A, Cupples LA, Huang K, Rosenberg CL. Genetically abnormal clones in histologically normal breast tissue. Am J Pathol 1998; 152: 1591-1598.
18. Smith HS, Lan S, Ceriani R, Hackett AJ, Stampfer MR. Clonal proliferation of cultured nonmalignant and malignant human breast epithelia. Cancer Res 1981; 41: 4637-4643.
19. Wolman SR, Smith HS, Stampfer M, Hackett AJ. Growth of diploid cells from breast cancers. Cancer Genet Cytogenet 1985; 16: 49-64.
20. Douek M, Vaidya JS, Lakhani SR, Hall-Craggs MA, Baum M, Taylor I. Can magnetic-resonance imaging help elucidate natural history of breast cancer multicentricity? Lancet 1998; 351: 801-802.
21. Connor F, Bertwistle D, Mee PJ, et al. Tumongenesis and a DNA repair defect in mice with a truncating BRCA2 mutation. Nature Genet 1997; 17: 423-430.
22. Sozzi G, Miozzo M, Tagliabue E, et al. Cytogenetic abnormalities and overexpression of receptors for growth factors in normal bronchial epithelium and tumor samples of lung cancer patients. Cancer Res 1991; 51: 400-404.
23. Limpens J, de Jong D, van Krieken JH, et al. Bcl-2/JH rearrangements in benign lymphoid tissues with follicular hyperplasia. Oncogene 1991; 6: 2271-2276.
24. Ford AM, Bennett CA, Price CM, Bruin MCA, Van Wering ER, Greaves M. Fetal origins of the TEL-AML1 fusion gene in identical twins with leukemia. Proc Natl Acad Sci USA 1998; 95: 4584-4588.
25. Sager R. Expression genetics in cancer: shifting the focus from DNA to RNA. Proc Natl Acad Sci USA 1997; 94: 952-955.